Published on 19 Mar 2018
Joao Andrade, chief executive of WideCells Group PLC (LON:WDC), and
chief scientific officer Peter Hollands tell Proactive about the
significance of the UK grant to work for research on a new form of stem
cell technology.
The new technology allows specialised adult cells such as skin cells to
be genetically re-programmed to be used in stem cell treatment and in
the study of disease.
Following the research project,
http://www.4-traders.com/WIDECELLS-GROUP-PLC-30353180/
http://www.4-traders.com/WIDECELLS-GROUP-PLC-30353180/
WideCells hopes to take these advanced
stem cells to a point of commercialisation so that the technology can be
included in the group’s stem cell service
No comments:
Post a Comment